Aristotle Atlantic Partners, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
Aristotle Atlantic Partners, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$245,0001,2000.03%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$94,902,00015.92%
Opaleye Management Inc. 407,002$13,333,0004.14%
Ikarian Capital, LLC 649,600$21,281,0002.80%
AWH Capital, L.P. 150,000$2,459,4572.54%
Boxer Capital, LLC 1,239,000$40,590,0002.09%
EcoR1 Capital, LLC 1,975,611$64,721,0002.02%
Camber Capital Management LP 1,500,000$49,140,0001.78%
MPM BioImpact LLC 180,000$5,897,0001.58%
Sofinnova Investments, Inc. 602,545$19,739,0001.50%
KRS Capital Management, LLC 28,141$921,0001.00%
View complete list of REATA PHARMACEUTICALS INC shareholders